Carrot Fertility began with a $35,000 out-of-pocket bill and grew into a global benefits platform spanning 130 countries. In a recent dialogue detailing the company's trajectory, Founder and CEO Tammy Sun detailed how her personal experience with high out-of-pocket costs of egg freezing sparked a mission to dismantle financial barriers. The platform now serves over 1,000 customers across 130 countries, offering a unified benefit system that supports members through maternity, parenting, and increasingly, menopause and low testosterone.
The company operates on a "preventive-first" methodology that emphasizes lower-level interventions. According to internal data validated by independent actuarial firm Milliman, two-thirds of Carrot members opt for less invasive options—such as fertility testing and nutrition support—over IVF when clinically appropriate. When IVF is necessary, Carrot reports a 93% single embryo transfer (SET) rate, which is 27% higher than the national average. This clinical focus has resulted in an IVF pregnancy rate of 60%, significantly outperforming the industry standard while reducing the high costs associated with multiple gestations and NICU admissions.
Sun is currently prioritizing the integration of menopause support within the global enterprise environment. With 1.1 billion women globally expected to have experienced menopause by 2025, the impact on workplace retention is substantial; Carrot’s research indicates that over half of affected women have considered employment changes due to symptoms. By making menopause care a standard component of healthcare benefits, Carrot aims to support women at the height of their careers, ensuring that reproductive health is recognized as a fundamental pillar of corporate infrastructure.
